Finerenone for chronic kidney disease in type 2 diabetes
نویسندگان
چکیده
Finerenone (Kerendia) is a mineralocorticoid-receptor antagonist for the treatment of chronic kidney disease in patients with type 2 diabetes. This article discusses its indications, efficacy and adverse effects.
منابع مشابه
Chronic kidney disease screening and renoprotection in type 2 diabetes.
BACKGROUND Type 2 diabetes (T2D) is a major cause of chronic kidney disease. Control of hypertension and the use of angiotensin converting enzyme inhibitors (ACEI) and/or angiotensin II receptor blockers especially in those with proteinuria have been shown to protect against chronic kidney disease and delay its progression to kidney failure. METHODS We reviewed the medical records of 169 pati...
متن کاملOne Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease
OBJECTIVE Individuals at high risk for chronic cardiometabolic disease (cardiovascular disease [CVD], type 2 diabetes, and chronic kidney disease [CKD]) share many risk factors and would benefit from early intervention. We developed a nonlaboratory-based risk-assessment tool for identification of people at high cardiometabolic disease risk. RESEARCH DESIGN AND METHODS Data of three population...
متن کاملHypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry
BACKGROUND In patients with type 2 diabetes, chronic kidney disease (CKD) is associated with increased risk of hypoglycaemia and death. Yet, it remains uncertain whether hypoglycaemia-associated mortality is modified by CKD. METHODS Type 2 diabetic patients, with or without CKD at enrolment were observed between 1995 and 2007, and followed up till 2009 at hospital medical clinics. We used add...
متن کاملclinical guidance on screening chronic kidney disease in type 2 diabetic patients for family physicians
incidence of diabetes is increasing in developing countries as well as iran. half of the patients are not aware of their disease so screening of diabetes is necessary. lifestyle changes in society, high-saturated fat diet and decreased physical activity are the factors that influence the growing rate of diabetes in iran.1 the need for addressing type 2 diabetes has been clarified for family phy...
متن کاملSUDOSCAN, an effective tool for screening chronic kidney disease in patients with type 2 diabetes
SUDOSCAN is a non-invasive method of measuring peripheral small fiber and autonomic nerve activity by detection of abnormal sweat gland function through electrochemical skin conductance. It has been reported to be an effective screening tool in early detection of microvascular type 2 diabetes mellitus (T2DM) complications including diabetic neuropathy and nephropathy in recent studies. However,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Prescriber
سال: 2023
ISSN: ['0959-6682', '1931-2253']
DOI: https://doi.org/10.1002/psb.2072